ask="12.5100"
ask_size="100"
average_daily_volume="10397"
bid="N/A"
bid_size="N/A"
book_value="2.6090"
change="+0.0332"
change_from_200_day_moving_average="-1.0222"
change_from_50_day_moving_average="-0.4001"
change_from_52_week_high="-2.4968"
change_From_52_week_low="0.5932"
change_in_percent="+1.0473%"
close="3.2032"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.7700"
ebitda="-19.70M"
eps_estimate_current_year="-1.6500"
eps_estimate_next_quarter="-0.4400"
eps_estimate_next_year="-1.7000"
ex_dividend_date="N/A"
float_shares="1878000"
high="3.3300"
high_52_weeks="5.7000"
last_trade_date="2/6/2017"
last_trade_price="3.2032"
last_trade_size="175"
last_trade_time="2:47pm"
low="2.9899"
low_52_weeks="2.6100"
market_capitalization="37.56M"
moving_average_200_day="4.2255"
moving_average_50_day="3.6033"
name="Nexvet Biopharma plc"
notes="N/A"
one_year_target_price="8.0000"
open="3.0900"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-24.1927%"
percent_change_from_50_day_moving_average="-11.1044%"
percent_change_from_52_week_high="-43.8035%"
percent_change_from_52_week_low="+22.7280%"
previous_close="3.1700"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.2150"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11726000"
short_ratio="15.7000"
stock_exchange="NGM"
symbol="NVET"
volume="16979"
weeks_range_52="2.6100 - 5.7000"
